Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study
CLINICAL INFECTIOUS DISEASES, cilt.69, sa.11, ss.1969-1979, 2019 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 69 Sayı: 11
- Basım Tarihi: 2019
- Doi Numarası: 10.1093/cid/ciz084
- Dergi Adı: CLINICAL INFECTIOUS DISEASES
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1969-1979
- İstanbul Üniversitesi Adresli: Evet
Özet
Background. (Pegylated) Interferon ([Peg]IFN) therapy leads to response in a minority of chronic hepatitis B (CHB) patients. Host genetic determinants of response are therefore in demand.